Pharmaceutical Process Validation Explained for Emerging Biotech Companies
Launching a commercial molecule safely requires a unified approach to architectural scale-up parameters. This professional analysis details the core stages of pharmaceutical process validation specifically for modern biotech startups. Learn how early-stage sponsors manage data integrity, establish system metrics, and validate commercial production suites smoothly in 2026.
Oral Solid Dose Tech Transfer: Common Delays and How to Avoid Them
Managing an oral solid dose tech transfer requires careful alignment of material properties and industrial machinery profiles. This comprehensive guide highlights the most common operational roadblocks that sponsors face during scaling. Discover expert strategies to optimize blending parameters, ensure cGMP compliance, and avoid unexpected launch delays in 2026.
Latest Articles
View All ArticlesInternational
Biologics
Pharmaceuticals
Logistics & Supply Chain
AI & Automation
Quality & Regulatory
News Capsules
— weekly intelligence in 60 seconds
Latest Expert Post
Direct-to-Patient Shipments: What I Said in 2021 — and What We See in 2026
Developing biosimilars involves navigating complex manufacturing and regulatory challenges that go far beyond traditional generics. This guide explores key hurdles—from analytical characterization to large-scale production—and highlights how strategic CDMO partnerships help ensure similarity, scalability, and commercial success.
Read Full Post
Cold Chain Logistics in Biologics Manufacturing: Preventing Temperature Excursions
Maintaining the integrity of temperature-sensitive therapies is the greatest challenge in modern medicine. This guide explores how cold chain logistics biologics manufacturing protocols prevent temperature excursions, utilize real-time monitoring, and ensure regulatory compliance. Learn about specialized packaging, risk mitigation strategies, and the role of CDMOs in securing the global supply chain.
Adventitious Agent Testing in Biologics: Building a CDMO Testing Strategy That Regulators Accept
Protecting biologics from viral, bacterial, and fungal contaminants is a regulatory mandate. This 2,500-word guide details Adventitious Agent Testing strategies at CDMOs. Explore in vitro and in vivo assays, Next-Generation Sequencing (NGS) trends, and how to structure your testing program to ensure safety and clinical success.
CDMO world AI Summer Series· Launches June 15
Learn how Ai is changing pharmaceutical manufacturing — features, roundtables, live videocasts.
Original Video Programming
Executive interviews, fill-finish features, and field intelligence from inside CDMO facilities.
Launching 5/12
Leadership Video Interview Series
Candid conversations with the CEOs, COOs, and CSOs redefining contract manufacturing.
Latest Report
Field Intelligence Reports
Boots-on-the-ground dispatches from inside CDMO facilities and pilot lines.
Now: Craig Mooney from CDSG.
Library
Pharma Problem Solved
Actionable solutions in small doses — short-form expert answers.
Latest: Dr. Frank Gibson on aseptic scale-up.
Inside the Facility — CDMO Walkthrough
Cicadea
Cicadea Biotech
A next-generation CDMO specializing in sterile fill-finish, lyophilization, and small-batch clinical supply for advanced biologics. Walk their cleanrooms, meet their team, and see the capacity behind their growing sponsor pipeline.
- • Sterile fill-finish (vials & syringes)
- • Lyophilization & aseptic processing
- • Phase I–III clinical supply
Want your facility featured next?
Put your capabilities in front of sponsors actively shopping for a CDMO partner.
Events to Attend
View All Events
Compaction Simulation Forum
CPHI Americas
CDMOworld Weekly Live Broadcast
15-Minute Industry Wrap-Up
A fast, focused live video broadcast covering the most important moves across the CDMO landscape — deals, capacity, regulatory shifts, and the people behind them.